Item 7.01 Regulation FD Disclosure
The replacement revolving credit facility is expected to be a five-year
revolving facility in the initial amount of up to
The replacement tranche A term loan facility, in the amount of up to
The Company intends to use the tranche A term loan facility under the Amended and Restated Credit Agreement and other financing to repay term loans outstanding under its Existing Credit Agreement (including all of the outstanding borrowings under the tranche B term loan facility, which is expected to be terminated in connection with the Amended and Restated Credit Agreement), and for general corporate purposes, which may include the repayment of other indebtedness.
The transactions described above are subject to the execution of definitive documentation and other customary closing conditions and there can be no assurance that the transactions will be consummated.
The information provided under this Item 7.01 is being furnished pursuant to Regulation FD and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section.
The information provided under this Item 7.01 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing. This Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely by Regulation FD.
Cautionary statement regarding forward-looking statements
This Current Report on Form 8-K contains "forward-looking statements" that
reflect our current estimates, expectations and projections about our future
results, performance, prospects and opportunities. Forward-looking statements
include, among other things, the information concerning our possible future
results of operations, business and growth strategies, financing plans,
expectations that regulatory developments or other matters will not have a
material adverse effect on our business or financial condition, our competitive
position and the effects of competition, the projected growth of the industry in
which we operate, and the benefits and synergies to be obtained from our
completed and any future acquisitions, and statements of our goals and
objectives, and other similar expressions concerning matters that are not
historical facts. Words such as "may," "will," "should," "could," "would,"
"predicts," "potential," "continue," "expects," "anticipates," "future,"
"intends," "plans," "believes," "estimates," "appears," "projects" and similar
expressions, as well as statements in future tense, identify forward-looking
statements. In evaluating those statements, you should specifically consider
various factors, including the risks related to healthcare industry trends and
those set forth herein and those detailed in our filings with the
Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements.
Given these uncertainties, risks and assumptions, as outlined above, you are cautioned not to place undue reliance on such forward-looking statements. Our actual results and financial condition could differ materially from those expressed in, or implied by, the forward-looking statements. Forward-looking statements speak only as of the date the statements are made. We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By: /s/Steve Filton Name :Steve Filton Title: Executive Vice President and
Chief Financial Officer
Date:
© Edgar Online, source